Clinical trials: Moderate Dementia
Alzheimer's Disease
Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
To evaluate the long-term safety and tolerability of idalopirdine (Lu AE58054) as adjunctive therapy to donepezil in patients with mild-moderate Alzheimer's Disease (AD).
- Trial name
- STAR Extension (NCT02079246)
- Testing
- Idalopirdine 60 mg
- Where
- 258 sites in United States, Argentina and 25 more
- Volunteers
- 1,463 people
- Sponsor
- H. Lundbeck A/S
Alzheimer's Disease
A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease
The purpose of this study is to evaluate the efficacy and safety of PF 04494700 in participants with mild to moderate Alzheimer's disease.
- Trial name
- NCT00566397
- Testing
- PF-04494700
- Where
- 62 sites in United States
- Volunteers
- 402 people
- Sponsor
- Pfizer